NCT04975984

Brief Summary

The aim of this study is to assess the efficacy and safety of expectant management in the treatment of tubal ectopic pregnancy and identification of different factors that can be used to predict its success.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

July 20, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 26, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

July 26, 2021

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

June 17, 2021

Last Update Submit

July 14, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • resolution of hCG level

    hCG levels measured every week till negative less than (\<20 IU/l) up to 12 weeks

    up to 12 weeks

Interventions

detect upper limit of qualitative hCG levels associated with successful expectant management of ectopic pregnancy

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants included in this study will have the following criteria: 1. Hemodynamically stable with confirmed diagnosis of ectopic pregnancy on ultrasound scan. 2. No significant pelvic pain. 3. No hemoperitoneum. 4. No fetal heart in the ectopic pregnancy. 5. HCG level \<5000 IU/L. 6. Expectant management was the first line of management offered to the patient after optimal counseling.

You may qualify if:

  • \- all women who underwent expectant management as the first line of management offered after optimal counseling during the period from January 1, 2016 to December 31, 2020.
  • Hemodynamically stable with confirmed diagnosis of ectopic pregnancy on ultrasound scan.
  • No significant pelvic pain.
  • No hemoperitoneum.
  • No fetal heart in the ectopic pregnancy.
  • HCG level \<5000 IU/L.
  • Expectant management was the first line of management offered to the patient after optimal counseling.

You may not qualify if:

  • all women with non tubal ectopic pregnancy
  • all women with tubal ectopic pregnancy that recieved medical or surgical treatment as 1st line treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams university maternity hospital

Cairo, Egypt

Location

MeSH Terms

Conditions

Pregnancy, Ectopic

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Radwa Rasheedy, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

June 17, 2021

First Posted

July 26, 2021

Study Start

July 20, 2021

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

July 26, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations